A Drug Regulatory Specialist serves as a key liaison between product developers and regulatory authorities, ensuring that therapeutic products comply with all applicable laws and guidelines. Their role involves compiling and submitting comprehensive documentation required for regulatory approvals, such as Investigational New Drug (IND) applications, New Drug Applications (NDA), and Marketing Authorization Applications (MAA). They carefully interpret complex regulatory requirements from agencies worldwide and provide strategic advice to align product development activities accordingly. By managing timelines and coordinating cross-functional teams, these specialists help streamline the approval process and minimize regulatory risks. Their work ensures that products meet the highest standards for safety, efficacy, and quality before reaching patients.
Beyond submissions, Drug Regulatory Specialists continuously monitor changes in regulations and guidance documents to ensure ongoing compliance throughout a product’s lifecycle. They assist in preparing responses to regulatory queries, supporting inspections and audits, and updating product information when necessary. Their expertise in navigating the global regulatory environment supports successful product launches and market access. This role demands strong communication skills, attention to detail, and the ability to adapt to evolving regulatory frameworks. Ultimately, their contributions are vital in bringing safe and effective treatments to patients while maintaining the integrity of the regulatory process.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada